Literature DB >> 25390140

Drug development: a complicated path.

Courtney Humphries.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25390140     DOI： 10.1038/515S4a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  2 in total

1.  Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies.

Authors:  Deepa Manwani; Paul S Frenette
Journal:  Blood       Date:  2013-09-19       Impact factor: 22.113

2.  5-hydroxymethyl-2-furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells.

Authors:  Osheiza Abdulmalik; Martin K Safo; Qiukan Chen; Jisheng Yang; Carlo Brugnara; Kwaku Ohene-Frempong; Donald J Abraham; Toshio Asakura
Journal:  Br J Haematol       Date:  2005-02       Impact factor: 6.998
  2 in total
  1 in total

1.  Advances in new drug therapies for the management of sickle cell disease.

Authors:  Kenneth I Ataga; Payal C Desai
Journal:  Expert Opin Orphan Drugs       Date:  2018-05-14       Impact factor: 0.694
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.